Authors:
Holvoet, P
Mertens, A
Verhamme, P
Bogaerts, K
Beyens, G
Verhaeghe, R
Collen, D
Muls, E
Van de Werf, F
Citation: P. Holvoet et al., Circulating oxidized LDL is a useful marker for identifying patients with coronary artery disease, ART THROM V, 21(5), 2001, pp. 844-848
Authors:
Kinard, F
Jaworski, K
Sergent-Engelen, T
Goldstein, D
Van Veldhoven, PP
Holvoet, P
Trouet, A
Schneider, YJ
Remacle, C
Citation: F. Kinard et al., Smooth muscle cells influence monocyte response to LDL as well as their adhesion and transmigration in a coculture model of the arterial wall, J VASC RES, 38(5), 2001, pp. 479-491
Authors:
Bosmans, JL
Holvoet, P
Dauwe, SEH
Ysebaert, DK
Chapelle, T
Jurgens, A
Kovacic, V
Van Marck, EA
De Broe, ME
Verpooten, GA
Citation: Jl. Bosmans et al., Oxidative modification of low-density lipoproteins and the outcome of renal allografts at 1 1/2 years, KIDNEY INT, 59(6), 2001, pp. 2346-2356
Authors:
Jaworski, K
Kinard, F
Goldstein, D
Holvoet, P
Trouet, A
Schneider, YJ
Remacle, C
Citation: K. Jaworski et al., S-nitrosothiols do not induce oxidative stress, contrary to other nitric oxide donors, in cultures of vascular endothelial or smooth muscle cells, EUR J PHARM, 425(1), 2001, pp. 11-19
Authors:
Quarck, R
De Geest, B
Stengel, D
Mertens, A
Lox, M
Theilmeier, G
Michiels, C
Raes, M
Bult, H
Collen, D
Van Veldhoven, P
Ninio, E
Holvoet, P
Citation: R. Quarck et al., Adenovirus-mediated gene transfer of human platelet-activating factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice, CIRCULATION, 103(20), 2001, pp. 2495-2500
Authors:
Holvoet, P
Van de Werf, F
Vanhaecke, J
Collen, D
Citation: P. Holvoet et al., Oxidized low-density lipoprotein and malondialdehyde-modified low-density lipoprotein: Markers of coronary artery disease, AM HEART MG, 2001, pp. 159-171
Authors:
Holvoet, P
Van Cleemput, J
Collen, D
Vanhaecke, J
Citation: P. Holvoet et al., Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease, ART THROM V, 20(3), 2000, pp. 698-702
Authors:
Holvoet, P
De Geest, B
Van Linthout, S
Lox, M
Danloy, S
Raes, K
Collen, D
Citation: P. Holvoet et al., The Arg123-Tyr166 central domain of human ApoAI is critical for Lecithin :Cholesterol acyltransferase-induced hyperalphalipoproteinemia and HDL remodeling in transgenic mice, ART THROM V, 20(2), 2000, pp. 459-466
Authors:
De Geest, B
Stengel, D
Landeloos, M
Lox, M
Le Gat, L
Collen, D
Holvoet, P
Ninio, E
Citation: B. De Geest et al., Effect of overexpression of human apo A-I in C57BL/6 and C57BL/6 apo E-deficient mice on 2 lipoprotein-associated enzymes, platelet-activating factoracetylhydrolase and paraoxonase - Comparison of adenovirus-mediated human apo A-I gene transfer and human apo A-I transgenesis, ART THROM V, 20(10), 2000, pp. E68-E75
Authors:
De Geest, B
Van Linthout, S
Lox, M
Collen, D
Holvoet, P
Citation: B. De Geest et al., Sustained expression of human apolipoprotein A-I after adenoviral gene transfer in C57BL/6 mice: Role of apolipoprotein A-I promoter, apolipoprotein A-I introns, and human apolipoprotein E enhancer, HUM GENE TH, 11(1), 2000, pp. 101-112
Authors:
Gillotte, KL
Zaiou, M
Lund-Katz, S
Anantharamaiah, GM
Holvoet, P
Dhoest, A
Palgunachari, MN
Segrest, JP
Weisgraber, KH
Rothblat, GH
Phillips, MC
Citation: Kl. Gillotte et al., Apolipoprotein-mediated plasma membrane microsolubilization - Role of lipid affinity and membrane penetration in the efflux of cellular cholesterol and phospholipid, J BIOL CHEM, 274(4), 1999, pp. 2021-2028